# Nebulized Versus Intravenous Tranexamic Acid for Hemoptysis

> **NCT07641946** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 170 (estimated)

## Conditions studied

- Hemoptysis
- Pulmonary Hemorrhage

## Interventions

- **DRUG:** nebulized tranexamic acid
- **DRUG:** Intravenous Tranexamic Acid

## Key facts

- **NCT ID:** NCT07641946
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-07
- **Final completion:** 2027-08
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07641946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07641946, "Nebulized Versus Intravenous Tranexamic Acid for Hemoptysis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07641946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*